Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PARP-1-IN-1 is a highly selective and orally active inhibitor of the enzyme PARP-1, with an IC50 value of 0.96 nM. It exhibits excellent tolerance and demonstrates significant activity in a single dose in the MDA-MB-436 xenotransplantation model [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 349,000 |
50 mg | 約10-14 週間 | ¥ 454,500 |
100 mg | 約10-14 週間 | ¥ 574,000 |
説明 | PARP-1-IN-1 is a highly selective and orally active inhibitor of the enzyme PARP-1, with an IC50 value of 0.96 nM. It exhibits excellent tolerance and demonstrates significant activity in a single dose in the MDA-MB-436 xenotransplantation model [1]. |
In vitro | PARP-1-IN-1 (compound Y49), over a 48-hour period, demonstrates effective inhibition of various cancer cells, with IC50 values of 9.64, 123.5, and 106.3 μM for MX-1, MCF7, and A548 cells, respectively. At concentrations ranging from 2.5 to 10 μM, it notably inhibits PARP-1 activity and decreases PAR production in A549 cells, exhibiting dose-dependent efficacy [1]. Western Blot Analysis confirms that PARP-1-IN-1, at 2.5 μM, 5 μM, and 10 μM concentrations and following a 48-hour incubation, successfully suppresses PARP-1 activity and lowers PAR levels in cancer cells, demonstrating its dose-dependent nature [1]. |
In vivo | PARP-1-IN-1 (Compound Y49) administered orally at a dosage of 50 mg/kg/day for 18 days significantly inhibits the growth of MDA-MB-436 tumors in female athymic BALB/c nude mice without causing a significant change in the body weight of the treated mice. This finding highlights the compound's potential as a targeted therapy for this tumor model. |
分子量 | 392.47 |
分子式 | C23H25FN4O |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PARP-1-IN-1 Inhibitor inhibitor inhibit